Park Hyatt
24th and M Sts. NW
Washington, DC
May 24-26, 2010
The Medical Device Manufacturers Association (MDMA) is the consistent voice representing the entrepreneurial, innovative medical technology industry. The 16th MDMA Annual Meeting provided an opportunity for members and non members to hear and discuss some of the most critical issues of concern to device manufacturers within the current legislative and regulatory environment.
Value of Attending
- Engage industry executives, government officials and expert panelists on critical issues
- Hear first-hand updates on the latest news and must have information for med-tech CEOs
- Build relationships while networking with more than 150 med-tech CEOs and senior executives
- Meet with your Congressional delegation on Capitol Hill
Agenda
Monday, May 24th
3:00 - 5:00 pm
Pre-Conference Registration
Hyde Park Foyer
6:00 - 7:30 pm
Opening Reception
Tivoli Room
Hosted by ALLERGAN
- Douglas Holtz-Eakin, President of the American Action Forum, Former Director of the Congressional Budget Office
Tuesday, May 25th
7:30 - 8:00 am
Meeting Registration
Hyde Park Foyer
8:00 - 9:45 am
Keynote Address and Networking Breakfast
Hyde Park Room
8:00-8:30 am
Welcome and Opening Remarks
Hyde Park Room
Mark Leahey, President & CEO, MDMA
Joe Kiani, Chairman and CEO, Masimo, MDMA Chairman
9:00-9:45 am
Keynote Address: Food and Drug Administration
Hyde Park Room
Joshua Sharfstein, M.D., Principal Deputy Commissioner, FDA, HHS
9:45-10:00 am
Networking Break
Hyde Park and Park Ballroom Foyers
10:00-10:45 am
What Lies Ahead for US MedTech Innovation
Park Ballroom
Dr. Makower will discuss the challenges of building a successful medical technology company in today's regulatory and political environment.
- Josh Makower M.D., Founder and CEO, ExploraMed Development
10:45-12:00 pm
The Impact of Health Care Reform on Medical Technology Companies
Park Ballroom
With the recent passage of health care reform, a panel of health policy experts will discuss the implications for device manufacturers in the years ahead. What impact will health reform have on the industry and what does it mean for innovation?
- David Bowen, Former Staff Director, US Senate Committee on Health, Education, Labor & Pensions
- Kelvyn Cullimore, Chairman, President and CEO, Dynatronics Corporation
- Paul LaViolette, Venture Partner, SV Life Sciences
12:00 - 1:30 pm
Keynote Luncheon
Hyde Park Room
- The Honorable Amy Klobuchar, U.S. Senator (D-MN)
1:45-3:00 pm
CDRH Update
Park Ballroom
- Jeffrey Shuren M.D., Director, CDRH
Reaction Panel and Q&A
Industry experts will discuss critical issues impacting the industry, including the need for greater predictability and transparency interacting with FDA, potential changes to the premarket review process and FDA's increased focus on post-market surveillance.
- John Manthei, Partner, Latham and Watkins
- Tom Afzal, President and CEO, Spinal Kinetics
- Guy Nohra, Co-Founder and Managing Director, Alta Partners
3:00-3:15 pm
Congressional Fly-in Briefing
Park Ballroom
Congressional fly-in participants will be briefed for their MDMA scheduled meetings on Capitol Hill.
3:30-5:00 pm
Congressional Fly-In
U.S. Senate and Congressional Buildings
Meeting participants will attend Hill meetings with their respective Senators and Representative to discuss issues affecting the innovative medical technology industry.
5:00-6:30 pm
MDMA Chairman's Reception
Hyde Park Room
Congressman Erik Paulsen (MN 3rd District) will receive the 2010 Chairman's Award for his tireless efforts on behalf of the medical device industry, and especially small companies. Congressman Paulsen continues to be a leading critic of policies that will stifle innovation in our industry. He was a leading opponent to the medical device tax included in the recently enacted health care reform legislation. In addition, his work in Congress exemplifies his commitment to assist medical device companies develop innovative medical therapies, improve patient care, and create thousands of device-related jobs in Minnesota and around the country.
Network with medical technology executives, government officials and other industry leaders while honoring Congressman Erik Paulsen for his continued commitment to the medical technology industry.
- The Honorable Erik Paulsen, U.S. Congressman (MN 3rd District)
Wednesday, May 26th
8:15-9:00 am
Continental Breakfast
Park Ballroom
9:00-9:45 am
Opportunities Abroad: What to Expect When Commercializing Outside the US
Park Ballroom
With greater regulatory challenges in the U.S., more companies are commercializing products overseas. A panel of executives with experience in international commercialization will share their experiences and strategies for success.
- Joe Kiani, Chairman and CEO, Masimo, MDMA Chairman
- Christopher Rowland, President & CEO, NeoTract, Inc.
9:45-10:15 am
Networking Break
Park Ballroom and Foyer
10:15-11:00 am
Practical Steps to Protect IP
Park Ballroom
This session will discuss the proactive steps companies should take to leverage their patent portfolio given recent administrative and potential legislative changes to the patent review process.
- Eb Bright, General Counsel and VP, Intellectual Property, Exploramed
- Jeff Grainger, Partner, The Foundry
- Steve Jenson, Partner, Knobbe Martens
11:00-12:15 pm
Reimbursement Challenges for Entrepreneurial Companies
In recent years, companies with innovative medical therapies have faced numerous challenges in coding, coverage and payment. The panel will discuss these challenges from the perspectives of a small business.
- Gretchen Benko-Mruk, Commercial Marketing Manager, Concentric Medical
- Charles Gilbride, Senior Director, Marketing and Business Development, Spinal Motion
- Patty Telgener, Senior Reimbursement Director, Emerson Consultants, Inc.
12:15-1:30 pm
Luncheon Address: Centers for Medicare and Medicaid Services
- Marc Hartstein, Deputy Director, Hospital and Ambulatory Policy Group, Center for Medicare, CMS
2010 Sponsors
Presenting Sponsor
Masimo
Gold Sponsors
Allergan, Inc.
Cook Medical
St. Jude Medical
Silver Sponsor
Conceptus
Merit Medical
Moog
NuVasive, Inc.
Emerson Consultants, Inc.
Knobbe Martens
Wilson Sonsini Godrich & Rosati
Bronze Sponsor
B. Braun OEM Division
Alta Partners
Supporting Organizations
BioMed GPS, LLC
The Food and Drug Law Institute (FDLI)
Health Industry Representatives Association (HIRA)
Media Sponsors
BNA, Inc.
FierceMarkets
The Gray Sheet
IN VIVO
MassDevice
Medical Product Outsourcing
medtech insight
onemedplace
START-UP
Cancellation & Refund Policy
If you cancel in writing on or before May 4, 2010, you will be refunded your registration fee after an administrative charge of $75. Cancellations not received by this date will not be eligible for a refund. No shows will not be refunded. Balances are due prior to the start of the event.
Sessions and speakers are subject to change without notice. MDMA reserves the right to cancel or reschedule any program, whereupon full registration fees will be refunded or applied to the rescheduled program in accordance with the registrant's preference. In the event of cancelled programs, MDMA assumes no responsibility for transportation, hotel, or other expenses incurred by registrants.
Questions
Call Erin Jones at (202) 354-7172.
